Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

Incidence, Natural History and Outcomes of Transient and Persistent Antiphospholipid Antibodies in Children and Young Adults with Provoked Venous Thromboembolism: Analysis of the Kids-DOTT Trial

Marisol Betensky, MDMPH, Anh Thy Nguyen, MSPH, Cristina Tarango, MD, Anupam R Verma, MD, Rukhmi Bhat, MDMS, Nicole Kucine, MD, Charles Nakar, MD, Gary Woods, MD, Frances L Hamblin, MSHS, RN, Ernest Amankwah, PhD, Neil A Goldenberg, MD PhD

Blood (2019) 134 (Supplement_1): 636.

https://doi.org/10.1182/blood-2019-131438

Published: 2019

Journal Articles

Comparison of the Serum Metabolic Signatures Based on 1 H NMR between Thrombotic Antiphospholipid Syndrome (APS) Patients and Healthy Individuals

Melissa Quintero, PhD, Silmara Aparecida De Lima Montalvão, PhD, Ljubica Tasic, PhD, Stephany Cares Huber, PhD, Joyce Maria Annichino- Bizzacchi, MD PhD

Blood (2019) 134 (Supplement_1): 5769.

https://doi.org/10.1182/blood-2019-131927

Published: 2019

Journal Articles

Monitoring Unfractionated Heparin Treatments. Stability of Plasma Anti-Xa Activity up to 4 Hours in Citrated Tubes

Anny Appert-Flory, MD, Florence Fischer, MD, Didier Jambou, MD, Sylvain Buvat, Marie-Helene Mahagne, MD, Pierre Toulon, MD

Blood (2019) 134 (Supplement_1): 3403.

https://doi.org/10.1182/blood-2019-130533

Published: 2019

Journal Articles

Modified Anti-FXa Assays for Measuring the Residual Activity of Apixaban and Rivaroxaban in Andexanet Alfa-Containing Samples on the ACL TOP Family ® Coagulation Analyzers

Anuja Khan, PhD, Krisjela Shishko, BS, Sam Arcidiacono, BS, Khanh Bui, BS, Genmin Lu, Pamela B. Conley, PhD, Anne Winkler, MD

Blood (2019) 134 (Supplement_1): 1153.

https://doi.org/10.1182/blood-2019-126254

Published: 2019

Journal Articles

Development of a Neural Network to Predict Thrombosis in the Antiphospholipid Syndrome with an Accuracy of 87%

Romy Kremers, PhD, Stéphane Zuily, MD PhD, Philip De Groot, PhD, Coenraad Hemker, MD PhD, Denis Wahl, MD PhD, Bas De Laat, MD, PhD

Blood (2018) 132 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2018-99-115834

Published: 2018

Journal Articles

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Sajida Kazi, MRCP, FRCPATH, Ann Kinga Malinowski, MD MSc, FRCSC, Clare Whitehead, Kevin H. M. Kuo, MDMSc, FRCPC, Lynda Harrington, Nancy Watts, Chen Wang, MD PhD FRCPC, Nadine Shehata, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 5077.

https://doi.org/10.1182/blood-2018-99-114949

Published: 2018

Journal Articles

Incidence of Thrombocytopenia and Heparin Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO) Compared to Cardiopulmonary Bypass and the Limited Sensitivity of Pre-Test Probability Score

Deepa Jayakody Arachchillage, MD MRCP, FRCPath, Sanjay Khanna, Christophe Vandenbriele, Jonthan Dutton, Alex Rosenberg, MRCP, FCICM, FFICM, TC Aw, FRCA, Winston Banya, Maurizio Passariello, EDIC, Michael Laffan, DM, FRCP, FRCPath, Stephane Ledot, EDIC, MD, Brijesh Patel, MRCP, FRCA, FFICM , PhD

Blood (2018) 132 (Supplement 1): 2451.

https://doi.org/10.1182/blood-2018-99-119143

Published: 2018

Journal Articles

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Stefano Barco, Stefanie Sollfrank, Alice Trinchero, Luigi Tomao, Barbara Zieger, Johanna A. Kremer Hovinga, MD Prof, Laura Conti, Anke Adenäuer, Erwin Miloni, Karl J. Lackner, Heidi Rossmann, Bernhard Lammle, MD

Blood (2018) 132 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2018-99-116030

Published: 2018

Journal Articles

Do Current Antiphospholipid Antibody Syndrome Guidelines Effectively Target at-Risk Obstetric Patients?

Kanika Thapar, BA, Nimesh Patel, BS, Bolanle Gbadamosi, MD, Daniel E Ezekwudo, MD, Ishmael Jaiyesimi, DO, MS, Marc Smith, MD

Blood (2018) 132 (Supplement 1): 1208.

https://doi.org/10.1182/blood-2018-99-119380

Published: 2018

Journal Articles

Measuring rFIX-Fc with 17 Different Combinations Coagulometers — Reagents: A Single Center Study

Thomas Sinegre, Adeline Trayaud, Maryse Tardieu, Laurie Talon, Aurélie Vaissade, Aurelien Lebreton

Blood (2018) 132 (Supplement 1): 5016.

https://doi.org/10.1182/blood-2018-99-114548

Published: 2018

Journal Articles

The Isotype of Antiphospholipid Antibodies and Their Associated Risk on Thrombosis and Pregnancy Morbidity; What Are the Odds?

Walid Chayouâ, MSc, Hilde Kelchtermans, PhD, Gary Moore, MD, Jean-Christophe Gris, MD PhD, Jacek Musial, MD PhD, Stéphane Zuily, MDPhD, Bas De Laat, MD, PhD, Katrien Devreese, PhD MD

Blood (2018) 132 (Supplement 1): 1220.

https://doi.org/10.1182/blood-2018-99-113361

Published: 2018

Journal Articles

Activity of a FIX-Padua Transgene Product in Commonly Used FIX:C One-Stage and Chromogenic Assay Systems Following PF-06838435 (SPK-9001) Gene Delivery

Mary Robinson, PhD, Lindsey A. George, MD, Benjamin J. Samelson-Jones, MD PhD, Valder R Arruda, MD PhD, Katherine A. High, MD, Marcus E Carr, MD PhD, Stefan Tiefenbacher, PhD

Blood (2018) 132 (Supplement 1): 2198.

https://doi.org/10.1182/blood-2018-99-119616

Published: 2018

Journal Articles

The Identification of High Risk APS Patients for Thrombosis with Triple Antiphospholipid Antibody Positivity Is Platform Dependent

Walid Chayouâ, MSc, Hilde Kelchtermans, PhD, Gary Moore, MD, Jacek Musial, MD PhD, Denis Wahl, MD PhD, Stéphane Zuily, MDPhD, Armando Tripodi, PhD, Pierre Fontana, MD PhD, Jasper A. Remijn, PhD, Bas De Laat, MD PhD, Katrien Devreese, MD PhD

Blood (2017) 130 (Supplement 1): 555.

https://doi.org/10.1182/blood.V130.Suppl_1.555.555

Published: 2017

Journal Articles

Lack of Inter-Laboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa Activity and the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time

Pierre Toulon, MD, Motalib Smahi, MD, Neila De Pooter, MD, Elamine Zereg

Blood (2017) 130 (Supplement 1): 3357.

https://doi.org/10.1182/blood.V130.Suppl_1.3357.3357

Published: 2017

Journal Articles

Poor Agreement between Commercially Available Anti-Cardiolipin and Anti-β2glycoprotein I IgG and IgM Solid Phase Assays Hampers Uniformity in the Classification of Antiphospholipid Syndrome Patients

Walid Chayouâ, MSc, Hilde Kelchtermans, PhD, Gary Moore, MD, Jean-Christophe Gris, MD PhD, Jacek Musial, MD PhD, Denis Wahl, MD PhD, Stéphane Zuily, MDPhD, Armando Tripodi, PhD, Pierre Fontana, MD PhD, Jasper A. Remijn, PhD, Bas De Laat, MD PhD, Katrien Devreese, MD PhD

Blood (2017) 130 (Supplement 1): 1059.

https://doi.org/10.1182/blood.V130.Suppl_1.1059.1059

Published: 2017

Journal Articles

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MBBS, Matthew A. Lunning, DO, Muhamed Baljevic, MD

Blood (2017) 130 (Supplement 1): 4917.

https://doi.org/10.1182/blood.V130.Suppl_1.4917.4917

Published: 2017

Journal Articles

CD39 and CD73 Activity Are Protective in a Mouse Model of Antiphospholipid Antibody-Induced Miscarriage

Harshal Nandurkar, MDPhD, Anushka Samudra, MSc, Karen Dwyer, MBBS, PhD FRACP, Carly Selan, BSc, Sussana Freddi, Mandana Nikpour, Michael Hickey, Karlheinz Peter, Simon Robson, Maithili Sashindranath, Peter Cowan

Blood (2017) 130 (Supplement 1): 459.

https://doi.org/10.1182/blood.V130.Suppl_1.459.459

Published: 2017

Journal Articles

Safety and Activity of Lenalidomide and Rituximab in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long-Term Follow-up of an Open-Label Phase II Trial

Melody R Becnel, MD, Loretta Nastoupil, MD, R. Eric Davis, MD, F. B. Hagemeister, MD, Michelle A. Fanale, MD, Luis Fayad, MD, Jason R. Westin, MD, Michael Wang, BS, Yasuhiro Oki, MD, Linda Claret, Sheryl G Forbes, Lei Feng, MS, Felipe Samaniego, MD, Sattva S. Neelapu, MD, Nathan Fowler, MD

Blood (2017) 130 (Supplement 1): 4040.

https://doi.org/10.1182/blood.V130.Suppl_1.4040.4040

Published: 2017

Journal Articles

Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity

Chur Woo You, MDPhD, Ho-Jin Shin, MD, Howard Levy, MBBCh, PhD, Martin Lee, PhD, Seung-Beom Hong, PhD, Jamie Ellen Siegel, MD, June Young Park, MD

Blood (2017) 130 (Supplement 1): 87.

https://doi.org/10.1182/blood.V130.Suppl_1.87.87

Published: 2017

Journal Articles

Absolute Lymphocyte Count after First Induction Is Associated with Relapse Free Survival in Acute Myeloid Leukemia

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Vera V. Troitskaya, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5087.

https://doi.org/10.1182/blood.V130.Suppl_1.5087.5087

Published: 2017

NARROW

Incidence, Natural History and Outcomes of Transient and Persistent Antiphospholipid Antibodies in Children and Young Adults with Provoked Venous Thromboembolism: Analysis of the Kids-DOTT Trial

Comparison of the Serum Metabolic Signatures Based on 1 H NMR between Thrombotic Antiphospholipid Syndrome (APS) Patients and Healthy Individuals

Monitoring Unfractionated Heparin Treatments. Stability of Plasma Anti-Xa Activity up to 4 Hours in Citrated Tubes

Modified Anti-FXa Assays for Measuring the Residual Activity of Apixaban and Rivaroxaban in Andexanet Alfa-Containing Samples on the ACL TOP Family ® Coagulation Analyzers

Development of a Neural Network to Predict Thrombosis in the Antiphospholipid Syndrome with an Accuracy of 87%

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Incidence of Thrombocytopenia and Heparin Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO) Compared to Cardiopulmonary Bypass and the Limited Sensitivity of Pre-Test Probability Score

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Do Current Antiphospholipid Antibody Syndrome Guidelines Effectively Target at-Risk Obstetric Patients?

Measuring rFIX-Fc with 17 Different Combinations Coagulometers — Reagents: A Single Center Study

The Isotype of Antiphospholipid Antibodies and Their Associated Risk on Thrombosis and Pregnancy Morbidity; What Are the Odds?

Activity of a FIX-Padua Transgene Product in Commonly Used FIX:C One-Stage and Chromogenic Assay Systems Following PF-06838435 (SPK-9001) Gene Delivery

The Identification of High Risk APS Patients for Thrombosis with Triple Antiphospholipid Antibody Positivity Is Platform Dependent

Lack of Inter-Laboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa Activity and the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time

Poor Agreement between Commercially Available Anti-Cardiolipin and Anti-β2glycoprotein I IgG and IgM Solid Phase Assays Hampers Uniformity in the Classification of Antiphospholipid Syndrome Patients

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

CD39 and CD73 Activity Are Protective in a Mouse Model of Antiphospholipid Antibody-Induced Miscarriage

Safety and Activity of Lenalidomide and Rituximab in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long-Term Follow-up of an Open-Label Phase II Trial

Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity

Absolute Lymphocyte Count after First Induction Is Associated with Relapse Free Survival in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only